Vimarsana
Biggest News Aggregation in the World

Page 30 - Aser Surgery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aser Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aser Surgery Today - Breaking & Trending Today

Simplifying the Maternal Care Network - Vimarsana News

Simplifying the Maternal Care Network

A new era in maternal care is emerging with the advent of maternity care management platforms. Innovative organizations are centralizing the coordination of all patient care aspects, seamlessly integrating with providers' electronic health records, existing workflows, and health information exchanges.

Neuro Biotech Alto Adds $128M in IPO Cash for Biomarker-Based Psych Drugs - Vimarsana News

Neuro Biotech Alto Adds $128M in IPO Cash for Biomarker-Based Psych Drugs

Alto Neuroscience will apply the IPO proceeds toward clinical tests of its psychiatric drugs in patients who exhibit certain biomarkers. The company's two most advanced programs are depression drugs in mid-stage development.

Personalized Medicine Is Revolutionizing the Role of Pharma Companies in the Healthcare Landscape - Vimarsana News

Personalized Medicine Is Revolutionizing the Role of Pharma Companies in the Healthcare Landscape

The more pharma companies do to become service providers in the personalized medicine era, the more they’ll succeed and the more lives they’ll help to save.

Cigna MA Sale to HCSC Could Still Clear Way for Humana Acquisition, Expert Says - Vimarsana News

Cigna MA Sale to HCSC Could Still Clear Way for Humana Acquisition, Expert Says

Despite Cigna and Humana ditching their pursuits to combine in December, one industry expert believes there's still a chance after Cigna announced its plan to sell its Medicare Advantage business to Health Care Service Corp.

Metabolic Disorder-Focused Fractyl Health 'GUTS' Out a $110 Million IPO - Vimarsana News

Metabolic Disorder-Focused Fractyl Health 'GUTS' Out a $110 Million IPO

Fractyl Health will use the IPO proceeds for pivotal testing of a medical device and surgical procedure intended to address root causes of diabetes and obesity. The Fractyl pipeline also includes a gene therapy for these conditions.